SCA
LOXO

Secor Capital Advisors’s Loxo Oncology, Inc LOXO Stock Holding History

Secor Capital Advisors’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31,689
Closed -$1.33M – 622
2017
Q1 		$1.33M Buy
+31,689
New +$1.31M 0.15% 201
2016
Q4 		– Sell
-12,887
Closed -$337K – 684
2016
Q3 		$337K Sell
12,887
-1,753
-12% -$45.9K 0.04% 422
2016
Q2 		$340K Buy
+14,640
New +$365K 0.04% 462

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Secor Capital Advisors's LOXO Position: Q2 2017 in Review

Secor Capital Advisors sold out of Loxo Oncology, Inc (LOXO) in Q2 2017, closing a stake of 31,689 shares — an estimated $1.33M sold.

Secor Capital Advisors first reported a position in LOXO in Q2 2016 and held it in 3 quarters. The position peaked at $1.33M in Q1 2017. 129 funds tracked by Wall St. Rank hold LOXO as of Q2 2017.

  • Secor Capital Advisors reported no remaining Loxo Oncology, Inc position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 31,689 Loxo Oncology, Inc shares in Q2 2017, an estimated $1.33M.
  • Secor Capital Advisors first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 3 quarters.
  • Secor Capital Advisors's Loxo Oncology, Inc position peaked at $1.33M in Q1 2017.
  • 129 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.